Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study

J Tabernero, E Van Cussem, Y Bang, C Fuchs, L Wyrwicz, K Lee, I Kudaba, M Garrido, C Chung, CC Salguero, W Mansoor, M Braghiroli, E Goekkurt, J Chao, Z Wainberg, U Kher, S Shah, S Karg, K Shitara

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)152-153
JournalAnnals of Oncology
Issue numberSuppl.4
Publication statusPublished - Jul 2019
Externally publishedYes
EventEuropean Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer - Barcelona, Spain
Duration: 3 Jul 20196 Jul 2019

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this